Filing Details

Accession Number:
0001104659-23-014611
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-08 17:12:20
Reporting Period:
2023-02-06
Accepted Time:
2023-02-08 17:12:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1609550 Inspire Medical Systems Inc. INSP Surgical & Medical Instruments & Apparatus (3841) 261377674
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1932219 John Rondoni C/O Inspire Medical Systems, Inc.
5500 Wayzata Blvd., Suite 1600
Golden Valley MN 55416
Chief Technology Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-02-06 490 $249.08 14,601 No 4 S Direct
Common Stock Disposition 2023-02-06 1,700 $249.91 12,901 No 4 S Direct
Common Stock Disposition 2023-02-06 949 $250.73 11,952 No 4 S Direct
Common Stock Disposition 2023-02-06 361 $251.72 11,591 No 4 S Direct
Common Stock Disposition 2023-02-08 940 $265.00 10,651 No 4 S Direct
Common Stock Disposition 2023-02-08 1,560 $270.00 9,091 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248.34 to $249.28, inclusive. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.41 to $250.40, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.42 to $251.34, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.42 to $252.06, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.